Brian E Fink

This inventor holds 45 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 22 EPO patents, primarily in Cancer Therapeutics. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brian E Fink. Retrieved from https://idiyas.com/inventor/brian-e-fink

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 45 (Patent Applications = 16)

% Patents Active = 95.6

CIPO Patents = 1

EPO Patents = 22 (Patent Applications = 19)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 160(Granted Patents)

Location History:

Princeton Junction, NJ (US) (2005 - 2010)
West Windsor, NJ (US) (2008 - 2011)
Yardley, PA (US) (2009 - 2024)

Company Filing History:

45 out of 3,745

Bristol-Myers Squibb Compnay

patents

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

KRAS Inhibitors

TGF Beta Antagonists

Cyclic Dinucleotides

Kinase Inhibitors

Prodrugs

Fluoroalkyl Compounds

Pyrrolotriazines

Androgen Receptor Modulators

Imidazotriazines

Anthranilic Acid Derivatives

Benzodiazepinones

Tricyclic Compounds

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760029 - KRAS G12D inhibitors (2026-10-13),

2. 12673954 - Benzofuran compounds as sting agonists (2026-07-07),

3. 12624033 - KRAS inhibitors (2026-05-12),

4. 12012374 - Agonists of ROR GAMMAt (2024-06-18),

5. 11945834 - Cyclic dinucleotides as anticancer agents (2024-04-02),

6. 11660311 - Cyclic dinucleotides as anticancer agents (2023-05-30),

7. 11427610 - Cyclic dinucleotides as anticancer agents (2022-08-30),

8. 11339185 - Cyclic dinucleotides as anticancer agents (2022-05-24),

9. 10953032 - Cyclic dinucleotides as anticancer agents (2021-03-23),

10. 10947263 - Cyclic dinucleotides as anticancer agents (2021-03-16),

11. 10744150 - Cyclic dinucleotides as anticancer agents (2020-08-18),

12. 10519187 - Cyclic dinucleotides as anticancer agents (2019-12-31),

13. 10399987 - TGF beta receptor antagonists (2019-09-03),

14. 10336761 - TGFβ receptor antagonist (2019-07-02),

15. 10292985 - TGF beta receptor antagonists (2019-05-21),

Title: The Inventor Brian E Fink: Pioneering Innovations in Yardley, PA

Introduction: Brian E Fink is a distinguished inventor based in Yardley, PA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Brian E Fink holds several patents in cutting-edge technologies related to renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to driving progress in these crucial areas.

Career Highlights: With a career spanning over two decades, Brian E Fink has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them. His work has not only revolutionized industries but has also improved the quality of life for many individuals around the world.

Collaborations: Throughout his career, Brian E Fink has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Brian E Fink's relentless pursuit of innovation and his passion for creating a positive impact on society have solidified his position as a respected inventor in Yardley, PA, and beyond. His work continues to inspire the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.